Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-03-01 5:19 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Point72 Asset Management L.P. | 6,899,669 6.4% | 6,899,669 (New Position) | View |
| 2021-02-19 4:27 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | SUVRETTA CAPITAL MANAGEMENT LLC | 31,827,500 5.9% | 31,827,500 (New Position) | View |
| 2021-02-16 4:53 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | BAKER BROS. ADVISORS LP | 39,631,929 11.4% | 39,631,929 (New Position) | View |
| 2021-02-16 4:30 pm Sale | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Vivo Capital IX LLC | 8,960,296 8.168% | -21,635,328 (-70.71%) | View |
| 2021-02-16 4:30 pm Sale | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | CITADEL ADVISORS LLC | 30,930,386 8.9% | -202,605 (-0.65%) | View |
| 2021-02-16 4:29 pm Sale | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Boxer Capital LLC | 10,309,250 9.1% | -10,052,625 (-49.37%) | View |
| 2021-02-12 5:00 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | ORBIMED ADVISORS LLC | 4,518,356 6.66% | 4,518,356 (New Position) | View |
| 2020-07-10 4:30 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Vivo Capital IX LLC | 30,595,624 9% | 16,480,873 (+116.76%) | View |
| 2020-07-10 4:02 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | CITADEL ADVISORS LLC | 31,132,991 8.9% | 31,132,991 (New Position) | View |
| 2020-07-10 10:48 am Sale | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | BlackRock Inc. BLK | 0 0% | -16,478,248 (Position Closed) | View |
| 2020-07-02 06:19 am Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Aspire Capital Fund LLC | 20,680,882 6.11% | 20,680,882 (New Position) | View |
| 2020-06-12 5:00 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Vivo Capital IX LLC | 14,114,751 6.6% | 14,114,751 (New Position) | View |
| 2020-06-05 4:31 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Boxer Capital LLC | 20,361,875 9.5% | 8,109,160 (+66.18%) | View |
| 2020-03-09 4:31 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | BlackRock Inc. BLK | 16,478,248 13.2% | 16,478,248 (New Position) | View |
| 2020-03-02 5:27 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Boxer Capital LLC | 12,252,715 9.8% | 12,252,715 (New Position) | View |